EVP R&D, Chief Medical Officer
Mon, Aug 3, 2026
17d ago
9,000 shares @ $48.58
Decreased holdings by -11.50%
20th largest trade (out of 157)
Planned (10b5-1)
“This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 39% above 200-day moving average